New Edition Gremlin Recombinant Protein Fc Tag Lyophilized Limited Time 60% Off [rFMw75aU]

High-Quality Gremlin Recombinant Protein

The New Edition Gremlin Recombinant Protein Fc Tag Lyophilized Limited Time 60% Off [rFMw75aU] from Innovative Research is a premium research-grade product designed for advanced laboratory applications. This recombinantly produced protein is derived from HEK293 cells, ensuring a high level of purity and reliability. The protein is buffered in a 50 mM Tris, 150 mM NaCl solution with a pH of 7.5 and contains 1 mM EDTA. With a purity of >95% as determined by SDS-PAGE, this protein is an ideal choice for your research needs. Key Features:

• Recombinantly produced in HEK293 cells for high purity
• Lyophilized for convenient storage and reconstitution
• Endotoxin level less than 1.0 EU per µg by the LAL method

Product Specifications and Properties

This New Edition Gremlin Recombinant Protein Fc Tag Lyophilized Limited Time 60% Off [rFMw75aU] is not just a high-purity protein; it also meets stringent quality control standards. It is produced with precision to ensure that it maintains its structural integrity and biological activity. The protein is stored lyophilized, which makes it easy to reconstitute and use. Technical Details:

• Source: HEK293 cells
• Storage Conditions: -20°C or lower for long-term storage
• Reconstitution: 50 mM Tris, 150 mM NaCl, pH 7.5 with 1 mM EDTA
• Purity: >95% by SDS-PAGE

Applications and Benefits

The New Edition Gremlin Recombinant Protein Fc Tag Lyophilized Limited Time 60% Off [rFMw75aU] is versatile and can be used in various experimental setups, including ELISA and Western blotting. Its high purity and specific activity make it an excellent tool for studying the function of Gremlin in cellular processes. This product is suitable for researchers in the fields of oncology, developmental biology, and immunology. Practical Uses:

• Research on BMP antagonist activity
• Investigation of Gremlin's role in carcinogenesis and kidney organogenesis
• Development of new therapeutic strategies in the context of cell proliferation and monocyte chemotaxis